Treatment type
GLP-1
Glucagon-like peptide-1 (and dual GIP/GLP-1) medicines for diabetes, weight, and labelled organ-protection uses. Authorized is not funded.
All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
No published breakthroughs for Switzerland yet. International articles stay on All countries. We are not filling this zoom with placeholder access.